BAILEY CHITWOOD: Open Payments
NPI 1912544669 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,160 in 149 payments from 21 companies in 2025. Trend: 2023 $3,057 · 2024 $3,688 · 2025 $4,160
Food & beverage: $3,980Education: $180
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $825 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 20 | $554 |
| Janssen Biotech, Inc. | 20 | $514 |
| GENZYME CORPORATION | 7 | $355 |
| Novartis Pharmaceuticals Corporation | 12 | $319 |
| LEO Pharma Inc. | 3 | $304 |
| UCB, Inc. | 6 | $299 |
| Galderma Laboratories, L.P. | 9 | $225 |
| E.R. Squibb & Sons, L.L.C. | 25 | $195 |
| Regeneron Healthcare Solutions, Inc. | 9 | $164 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, ILUMYA, COSENTYX, Bimzelx, Winlevi, Sotyktu.
Industry payments across TN — which companies pay providers there.
